GPR75: An exciting new target in metabolic syndrome and related disorders

GPR75: An exciting new target in metabolic syndrome and related disorders

The metabolic syndrome is a plethora of related disorders that are frequently associated with morbidity and mortality in addition to economic burden. While various treatment options are available, the need to understand the pathology and find new targets still remains. Recent data have suggested GPR...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochimie 2022-04, Vol.195, p.19-26
Hauptverfasser: Murtaza, Babar, Asghar, Faiza, Patoli, Danish
Format: Artikel
Sprache:eng
Schlagworte:
20-HETE
CCL5
GPR75
Metabolic syndrome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 26
container_issue
container_start_page 19
container_title Biochimie
container_volume 195
creator Murtaza, Babar
Asghar, Faiza
Patoli, Danish
description The metabolic syndrome is a plethora of related disorders that are frequently associated with morbidity and mortality in addition to economic burden. While various treatment options are available, the need to understand the pathology and find new targets still remains. Recent data have suggested GPR75 as one such exciting target that has shown to a highly druggable potential. In this review, we have discussed the recent findings on GPR75 in terms of its expression and signaling and the way it could be a novel target in diseases associated with metabolic syndrome including obesity, dyslipidemia, diabetes, cardiovascular disease, and cerebrovascular disease. In addition, the opportunities and challenges related with the druggable potential of GPR75 have also been highlighted in this review. •Recent reports have attracted immense interest in GPR75.•Overview of GPR75 receptor expression and signaling has been provided.•We describe how GPR75 maybe a novel target in metabolic syndrome.•The opportunities and challenges.
doi_str_mv 10.1016/j.biochi.2022.01.005
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2621656504</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0300908422000141</els_id><sourcerecordid>2621656504</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-12628676c7a26fc54fbecfe451cd7195ea62264f8fcf24e6197c0a6200bd62c83</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotn78A5Ecvew6yW6yWw9CKVoLBUX0HLLJrKbsR022fvx7I60ePQ0Mz8zL-xByxiBlwOTlKq1cb15dyoHzFFgKIPbImMmsTCQrs30yhgwgmUCZj8hRCCuIBPDJIRllAnKRZWJMFvOHx0Jc0WlH8dO4wXUvtMMPOmj_ggN1HW1x0FXfOEPDV2d93yLVnaUeGz2gpdaF3lv04YQc1LoJeLqbx-T59uZpdpcs7-eL2XSZmEzyIWFc8lIW0hSay9qIvK7Q1JgLZmzBJgK15FzmdVmbmuco2aQwEHcAlZXclNkxudj-Xfv-bYNhUK0LBptGd9hvgor_mRQyNoxovkWN70PwWKu1d632X4qB-pGoVmorUf1IVMBUVBTPzncJm6pF-3f0ay0C11sAY893h14F47AzaJ1HMyjbu_8TvgFWwYNb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2621656504</pqid></control><display><type>article</type><title>GPR75: An exciting new target in metabolic syndrome and related disorders</title><source>Access via ScienceDirect (Elsevier)</source><creator>Murtaza, Babar ; Asghar, Faiza ; Patoli, Danish</creator><creatorcontrib>Murtaza, Babar ; Asghar, Faiza ; Patoli, Danish</creatorcontrib><description>The metabolic syndrome is a plethora of related disorders that are frequently associated with morbidity and mortality in addition to economic burden. While various treatment options are available, the need to understand the pathology and find new targets still remains. Recent data have suggested GPR75 as one such exciting target that has shown to a highly druggable potential. In this review, we have discussed the recent findings on GPR75 in terms of its expression and signaling and the way it could be a novel target in diseases associated with metabolic syndrome including obesity, dyslipidemia, diabetes, cardiovascular disease, and cerebrovascular disease. In addition, the opportunities and challenges related with the druggable potential of GPR75 have also been highlighted in this review. •Recent reports have attracted immense interest in GPR75.•Overview of GPR75 receptor expression and signaling has been provided.•We describe how GPR75 maybe a novel target in metabolic syndrome.•The opportunities and challenges.</description><identifier>ISSN: 0300-9084</identifier><identifier>EISSN: 1638-6183</identifier><identifier>DOI: 10.1016/j.biochi.2022.01.005</identifier><identifier>PMID: 35045335</identifier><language>eng</language><publisher>France: Elsevier B.V</publisher><subject>20-HETE ; CCL5 ; GPR75 ; Metabolic syndrome</subject><ispartof>Biochimie, 2022-04, Vol.195, p.19-26</ispartof><rights>2022 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM)</rights><rights>Copyright © 2022 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-12628676c7a26fc54fbecfe451cd7195ea62264f8fcf24e6197c0a6200bd62c83</citedby><cites>FETCH-LOGICAL-c362t-12628676c7a26fc54fbecfe451cd7195ea62264f8fcf24e6197c0a6200bd62c83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.biochi.2022.01.005$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35045335$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Murtaza, Babar</creatorcontrib><creatorcontrib>Asghar, Faiza</creatorcontrib><creatorcontrib>Patoli, Danish</creatorcontrib><title>GPR75: An exciting new target in metabolic syndrome and related disorders</title><title>Biochimie</title><addtitle>Biochimie</addtitle><description>The metabolic syndrome is a plethora of related disorders that are frequently associated with morbidity and mortality in addition to economic burden. While various treatment options are available, the need to understand the pathology and find new targets still remains. Recent data have suggested GPR75 as one such exciting target that has shown to a highly druggable potential. In this review, we have discussed the recent findings on GPR75 in terms of its expression and signaling and the way it could be a novel target in diseases associated with metabolic syndrome including obesity, dyslipidemia, diabetes, cardiovascular disease, and cerebrovascular disease. In addition, the opportunities and challenges related with the druggable potential of GPR75 have also been highlighted in this review. •Recent reports have attracted immense interest in GPR75.•Overview of GPR75 receptor expression and signaling has been provided.•We describe how GPR75 maybe a novel target in metabolic syndrome.•The opportunities and challenges.</description><subject>20-HETE</subject><subject>CCL5</subject><subject>GPR75</subject><subject>Metabolic syndrome</subject><issn>0300-9084</issn><issn>1638-6183</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LAzEQhoMotn78A5Ecvew6yW6yWw9CKVoLBUX0HLLJrKbsR022fvx7I60ePQ0Mz8zL-xByxiBlwOTlKq1cb15dyoHzFFgKIPbImMmsTCQrs30yhgwgmUCZj8hRCCuIBPDJIRllAnKRZWJMFvOHx0Jc0WlH8dO4wXUvtMMPOmj_ggN1HW1x0FXfOEPDV2d93yLVnaUeGz2gpdaF3lv04YQc1LoJeLqbx-T59uZpdpcs7-eL2XSZmEzyIWFc8lIW0hSay9qIvK7Q1JgLZmzBJgK15FzmdVmbmuco2aQwEHcAlZXclNkxudj-Xfv-bYNhUK0LBptGd9hvgor_mRQyNoxovkWN70PwWKu1d632X4qB-pGoVmorUf1IVMBUVBTPzncJm6pF-3f0ay0C11sAY893h14F47AzaJ1HMyjbu_8TvgFWwYNb</recordid><startdate>202204</startdate><enddate>202204</enddate><creator>Murtaza, Babar</creator><creator>Asghar, Faiza</creator><creator>Patoli, Danish</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202204</creationdate><title>GPR75: An exciting new target in metabolic syndrome and related disorders</title><author>Murtaza, Babar ; Asghar, Faiza ; Patoli, Danish</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-12628676c7a26fc54fbecfe451cd7195ea62264f8fcf24e6197c0a6200bd62c83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>20-HETE</topic><topic>CCL5</topic><topic>GPR75</topic><topic>Metabolic syndrome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murtaza, Babar</creatorcontrib><creatorcontrib>Asghar, Faiza</creatorcontrib><creatorcontrib>Patoli, Danish</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biochimie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murtaza, Babar</au><au>Asghar, Faiza</au><au>Patoli, Danish</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>GPR75: An exciting new target in metabolic syndrome and related disorders</atitle><jtitle>Biochimie</jtitle><addtitle>Biochimie</addtitle><date>2022-04</date><risdate>2022</risdate><volume>195</volume><spage>19</spage><epage>26</epage><pages>19-26</pages><issn>0300-9084</issn><eissn>1638-6183</eissn><abstract>The metabolic syndrome is a plethora of related disorders that are frequently associated with morbidity and mortality in addition to economic burden. While various treatment options are available, the need to understand the pathology and find new targets still remains. Recent data have suggested GPR75 as one such exciting target that has shown to a highly druggable potential. In this review, we have discussed the recent findings on GPR75 in terms of its expression and signaling and the way it could be a novel target in diseases associated with metabolic syndrome including obesity, dyslipidemia, diabetes, cardiovascular disease, and cerebrovascular disease. In addition, the opportunities and challenges related with the druggable potential of GPR75 have also been highlighted in this review. •Recent reports have attracted immense interest in GPR75.•Overview of GPR75 receptor expression and signaling has been provided.•We describe how GPR75 maybe a novel target in metabolic syndrome.•The opportunities and challenges.</abstract><cop>France</cop><pub>Elsevier B.V</pub><pmid>35045335</pmid><doi>10.1016/j.biochi.2022.01.005</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0300-9084
ispartof Biochimie, 2022-04, Vol.195, p.19-26
issn 0300-9084
1638-6183
language eng
recordid cdi_proquest_miscellaneous_2621656504
source Access via ScienceDirect (Elsevier)
subjects 20-HETE
CCL5
GPR75
Metabolic syndrome
title GPR75: An exciting new target in metabolic syndrome and related disorders
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T20%3A06%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=GPR75:%20An%20exciting%20new%20target%20in%20metabolic%20syndrome%20and%20related%20disorders&rft.jtitle=Biochimie&rft.au=Murtaza,%20Babar&rft.date=2022-04&rft.volume=195&rft.spage=19&rft.epage=26&rft.pages=19-26&rft.issn=0300-9084&rft.eissn=1638-6183&rft_id=info:doi/10.1016/j.biochi.2022.01.005&rft_dat=%3Cproquest_cross%3E2621656504%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2621656504&rft_id=info:pmid/35045335&rft_els_id=S0300908422000141&rfr_iscdi=true